ContactMeet the Experts Empowering Your MedTech Success
At IGES MedTech, we actively engage with the global MedTech community through industry-leading events and exclusive webinars. These occasions provide a unique opportunity to connect with our experts, gain actionable insights, and discuss how we can support your journey to market success.
Whether you're attending an international conference or joining one of our webinars, our team is ready to share expertise and explore tailored strategies to help your medical device succeed in today's competitive healthcare landscape.
Below, you'll find details of our upcoming events and webinars. Let's meet and work together to bring innovative solutions to patients worldwide.
Join Our Upcoming Webinars at IGES MedTech
Wednesday, 04.06.2025
Online
Mattias Kyhlstedt, Michel Verhasselt, Michael Weisser
Webinar
EU HTA PICO and Evidence Strategy for Medtech and IVD
With the new EU HTA regulation, a process has been established to harmonise the PICO scope for the joint EU HTA evaluation.
- Patient
- Intervention
- Comparator
- Outcomes
The process involves asking all the member states about the appropriate PICO from a policy perspective.
From the experience in both pharma and medical devices, this has led to many different PICO schemes, making the evidence development complex for companies.
How should the study be designed to ensure successful outcomes in reimbursement and HTA processes?
In this session, we’ll cover:
- What is the EU HTA PICO process?
- What insights can be made from the pilot project?
- Clinical and Economic Evidence Requirements across Europe
- The role of the Joint Scientific Consultation
- A review of how the PICO applies to:
- Germany
- France
- Recommended actions to help you prepare for these changes.
Meet the IGES MedTech Team at Leading Industry Events
Wednesday, 04.06.2025
Online
Mattias Kyhlstedt, Michel Verhasselt, Michael Weisser
Webinar
EU HTA PICO and Evidence Strategy for Medtech and IVD
With the new EU HTA regulation, a process has been established to harmonise the PICO scope for the joint EU HTA evaluation.
- Patient
- Intervention
- Comparator
- Outcomes
The process involves asking all the member states about the appropriate PICO from a policy perspective.
From the experience in both pharma and medical devices, this has led to many different PICO schemes, making the evidence development complex for companies.
How should the study be designed to ensure successful outcomes in reimbursement and HTA processes?
In this session, we’ll cover:
- What is the EU HTA PICO process?
- What insights can be made from the pilot project?
- Clinical and Economic Evidence Requirements across Europe
- The role of the Joint Scientific Consultation
- A review of how the PICO applies to:
- Germany
- France
- Recommended actions to help you prepare for these changes.
